take-photo-shutterstock-com
Take Photo / Shutterstock.com
18 November 2015Europe

English High Court affirms the validity of Eli Lilly’s ADHD patent

The English High Court has affirmed the validity of Eli Lilly’s European patent covering the use of the drug Strattera (atomoxetine), used to treat attention-deficit hyperactivity disorder (ADHD).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk